Targeting mitochondria metabolism for cancer therapy

被引：1110

作者：

Weinberg, Samuel E. ^{[1
]}

Chandel, Navdeep S. ^{[1
]}

机构：

[1] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA

来源：

NATURE CHEMICAL BIOLOGY | 2015年 / 11卷 / 01期

基金：

美国国家卫生研究院;

关键词：

CELL LUNG-CANCER; GLUTAMINE-METABOLISM; OXIDATIVE-PHOSPHORYLATION; DEGENERATIVE DISEASES; ENERGY-METABOLISM; TUMOR-CELLS; METFORMIN; GROWTH; INHIBITION; GLUCOSE;

D O I：

10.1038/nchembio.1712

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Mitochondria have a well-recognized role in the production of ATP and the intermediates needed for macromolecule biosynthesis, such as nucleotides. Mitochondria also participate in the activation of signaling pathways. Overall, accumulating evidence now suggests that mitochondrial bioenergetics, biosynthesis and signaling are required for tumorigenesis. Thus, emerging studies have begun to demonstrate that mitochondrial metabolism is potentially a fruitful arena for cancer therapy. In this Perspective, we highlight recent developments in targeting mitochondrial metabolism for the treatment of cancer. npg (C) 2015 Nature America, Inc. All rights reserved.

引用

页码：9 / 15

页数：7

共 102 条

[1] Protein Phosphorylation and Prevention of Cytochrome Oxidase Inhibition by ATP: Coupled Mechanisms of Energy Metabolism Regulation [J].

Acin-Perez, Rebeca ;

Gatti, Domenico L. ;

Bai, Yidong ;

Manfredi, Giovanni .

CELL METABOLISM, 2011, 13 (06) :712-719

[2] OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].

AMES, BN ;

SHIGENAGA, MK ;

HAGEN, TM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922

[3] Phenformin as prophylaxis and therapy in breast cancer xenografts [J].

Appleyard, M. V. C. L. ;

Murray, K. E. ;

Coates, P. J. ;

Wullschleger, S. ;

Bray, S. E. ;

Kernohan, N. M. ;

Fleming, S. ;

Alessi, D. R. ;

Thompson, A. M. .

BRITISH JOURNAL OF CANCER, 2012, 106 (06) :1117-1122

[4] Drug therapy - Metformin [J].

Bailey, CJ ;

Turner, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579

[5] Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides [J].

Birsoy, Kivanc ;

Possemato, Richard ;

Lorbeer, Franziska K. ;

Bayraktar, Erol C. ;

Thiru, Prathapan ;

Yucel, Burcu ;

Wang, Tim ;

Chen, Walter W. ;

Clish, Clary B. ;

Sabatini, David M. .

NATURE, 2014, 508 (7494) :108-+

[6] Targeting cancer metabolism: a bedside lesson [J].

Birsoy, Kivanc ;

Sabatini, David M. ;

Possemato, Richard .

NATURE MEDICINE, 2012, 18 (07) :1022-1023

[7] Surviving antioxidant supplements [J].

Bjelakovic, Goran ;

Gluud, Christian .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (10) :742-743

[8] A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth [J].

Bonnet, Sebastien ;

Archer, Stephen L. ;

Allalunis-Turner, Joan ;

Haromy, Alois ;

Beaulieu, Christian ;

Thompson, Richard ;

Lee, Christopher T. ;

Lopaschuk, Gary D. ;

Puttagunta, Lakshmi ;

Bonnet, Sandra ;

Harry, Gwyneth ;

Hashimoto, Kyoko ;

Porter, Christopher J. ;

Andrade, Miguel A. ;

Thebaud, Bernard ;

Michelakis, Evangelos D. .

CANCER CELL, 2007, 11 (01) :37-51

[9] Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria [J].

Bridges, Hannah R. ;

Jones, Andrew J. Y. ;

Pollak, Michael N. ;

Hirst, Judy .

BIOCHEMICAL JOURNAL, 2014, 462 :475-487

[10] Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth [J].

Buzzai, Monica ;

Jones, Russell G. ;

Amaravadi, Ravi K. ;

Lum, Julian J. ;

DeBerardinis, Ralph J. ;

Zhao, Fangping ;

Viollet, Benoit ;

Thompson, Craig B. .

CANCER RESEARCH, 2007, 67 (14) :6745-6752

← 1 2 3 4 5 6 7 8 9 10 →